Sherbrooke Park Advisers’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-178,521
Closed -$625K 1054
2024
Q2
$625K Buy
+178,521
New +$625K 0.11% 313